"There is something intrinsically sacrificial about participating in biomedical research. Research exposes participants to some risks and often offer little no individual benefits. In some rare and extreme cases, research participants make the ultimate sacrifice: they die as a result of the intervention being tested. When this happens, there is a strong intuition that the participant's family should receive compensation for their loss. The intuition is also embedded in influential ethics guidance that researchers and their funders are supposed to adhere to: those conducting clinical trials are required to have insurance to cover such eventualities."
-Global bioethics blog
"Clinical trials claimed 25 lives in 2010, only 5 paid compensation"
"NEW DELHI: Rs 3 lakh – that's the price a pharmaceutical company has paid to the family of a person who died in their clinical trial. Others weren't even this lucky.
According to the Drug Controller General of India's (DCGI) records, 25 people died in clinical trials carried out by nine pharmaceutical companies in 2010. Families of five of these victims received "compensation for trial related death" — the amount ranging from Rs 1.5 lakh to Rs 3 lakh."
-The Times of India